Cell Therapy Market Players:
- Nkarta, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG
- Gilead Sciences, Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc
- JCR Pharmaceuticals Co., Ltd.
- JW Therapeutics
- Atara Biotherapeutics
- Anterogen Co., Ltd.
- MEDIPOST Co., Ltd.
- S. BIOMEDICS
- Aurion Biotech
- Cytiva
- Pluri Biotech Ltd.
The market for cell therapy consists of many key players who are launching various strategic initiatives to expand their market position in the industry.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cell therapy is assessed at USD 16.56 billion.
The global cell therapy market size surpassed USD 14.22 billion in 2025 and is projected to witness a CAGR of around 18.3%, crossing USD 76.34 billion revenue by 2035.
North America cell therapy market will dominate around 59% share by 2035, driven by increased medical R&D and healthcare expenditure.
Key players in the market include Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc, JCR Pharmaceuticals Co., Ltd., JW Therapeutics, Atara Biotherapeutics.
